Rhinology - PDFSEARCH.IO - Document Search Engine

Rhinology
Results: 169

#	Item
31	Intersect ENT Appoints Chas McKhann as Chief Commercial Officer Menlo Park, Calif. – February 2, 2015––Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, Add to Reading List Source URL: propelopens.com Language: English - Date: 2015-02-03 12:17:27 Headaches Sinusitis Otolaryngology Sinus Drug-eluting stent Medicine Rhinology General practice
32	Intersect ENT Named One of the “Fierce 15” Most Promising Private Companies by FierceMedicalDevices Menlo Park, Calif. – Oct. 15, 2013 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:02 General practice Headaches Sinusitis Sinus Otolaryngology U.S. Venture Partners Medtronic Medicine Health Rhinology
33	Intersect ENT Initiates U.S. Clinical Study of a Novel In-Office Treatment for Chronic Sinusitis Patients RESOLVE Study Will Evaluate Safety and Effectiveness of Steroid-Eluting Implant for Post-Sinus Surgery Patients wi Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:35 Headaches Sinusitis Otolaryngology Sinus Balloon sinuplasty Medicine Rhinology General practice
34	Intersect ENT Named One of Forbes Magazine’s “America’s Most Promising Companies” of 2014 Menlo Park, Calif. – Jan. 23, 2014 – Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:37 General practice Headaches Sinusitis Sinus Otolaryngology Medtronic Mometasone furoate Medicine Health Rhinology
35	Groundbreaking Clinical Evidence Demonstrates Benefit of PROPEL Implant for Chronic Sinusitis Patients Results Published in Two Peer-Reviewed Journals Show Significant Reduction in Need for Additional Surgical Interventi Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:36 Rhinology Sinusitis Otolaryngology Sinus Medicine General practice Headaches
36	Intersect ENT Announces FDA Approval of New Steroid-Releasing Implant, Allowing More Chronic Sinusitis Patients to Benefit from Localized Drug Delivery PROPEL™ mini Offers Same Clinical Benefits and Dose of Mometasone Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:10:29 Headaches Rhinology Sinusitis Otolaryngology Mometasone furoate Sinus Clinical trial Medicine Health General practice
37	IntersectENT Release[removed]FINAL Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:43 General practice Headaches Sinusitis Drug-eluting stent Sinus Medicine Rhinology Interventional cardiology
38	Press Release - Propel FDA Approval[removed]FINAL Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:22 Headaches Rhinology Sinusitis Sinus Functional endoscopic sinus surgery Mometasone furoate Balloon sinuplasty Nasal polyp Medicine Otolaryngology General practice
39	Series D financing draft B.docx.docx Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:57 Anatomy Sinus Otolaryngology Medtronic Norwest Venture Partners Kleiner Perkins Caufield & Byers Medicine Health Rhinology
40	Media Contact: Nicole Osmer[removed]removed] Intersect ENT Quadruples Operation Size with Expansion to New Facility in Menlo Park, Calif. Add to Reading List Source URL: propelopens.com Language: English - Date: 2014-04-17 10:11:54 General practice Headaches Sinusitis Otolaryngology Sinus Paranasal sinuses Medtronic Medicine Human anatomy Rhinology

UPDATE